EcoDrugPlus

Ensembl ID : ENSPNYG00000021623
Gene Symbol: -
Cross references: -
198 Possible Orthologues:

Ensembl ID : ENSPNYG00000022366
Gene Symbol: -
Cross references: -
184 Possible Orthologues:

Ensembl ID : ENSPNYG00000022338
Gene Symbol: -
Cross references: -
210 Possible Orthologues:

Ensembl ID : ENSPNYG00000006150
Gene Symbol: -
Cross references: -
213 Possible Orthologues:

Ensembl ID : ENSPNYG00000005247
Gene Symbol: -
Cross references: -
133 Possible Orthologues:

Ensembl ID : ENSPNYG00000006700
Gene Symbol: -
Cross references: -
232 Possible Orthologues:

Ensembl ID : ENSPNYG00000005513
Gene Symbol: -
Cross references: -
248 Possible Orthologues:

Ensembl ID : ENSPNYG00000019134
Gene Symbol: -
Cross references: -
208 Possible Orthologues:

Ensembl ID : ENSPNYG00000019336
Gene Symbol: -
Cross references: -
153 Possible Orthologues:

Ensembl ID : ENSPNYG00000004419
Gene Symbol: -
Cross references: -
35 Possible Orthologues:

Ensembl ID : ENSPNYG00000011580
Gene Symbol: -
Cross references: -
188 Possible Orthologues:

Ensembl ID : ENSPNYG00000023072
Gene Symbol: -
Cross references: -
193 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).